期刊文献+

非诺贝特对高胆固醇喂养兔主动脉斑块面积和肿瘤坏死因子α的影响 被引量:5

The Effects of Fenofibrate to Aortic Atherosclerotic Area and Serum Tumor Necrosis Factor-a in the Cholesterol-Fed Rabbits
暂未订购
导出
摘要 目的利用高脂饮食诱发动脉粥样硬化模型,观察非诺贝特的抗动脉粥样硬化作用,并探讨其机制。方法10只新西兰大白兔给予高胆固醇饮食饲养8周后,随机分为两组:高胆固醇组继续饲以高胆固醇饲料4周;非诺贝特组在饲以高胆固醇饲料的基础上给予非诺贝特[30 mg/(kg.d)],共4周。另选择普通饮食12周兔(n=5)作为对照组。测定饲养前后血清肿瘤坏死因子α水平和饲养后的主动脉斑块面积。半定量逆转录聚合酶链反应测定脂肪组织肿瘤坏死因子αmRNA的表达。结果非诺贝特组和高胆固醇组血清总胆固醇、低密度脂蛋白胆固醇水平均明显高于对照组(P<0.001),但两组间差异无显著性。非诺贝特组与高胆固醇组相比主动脉斑块面积(52.81%±6.92%比76.30%±8.61%,P<0.01)、血管内膜厚度(28.45±5.68μm比76.18±11.25μm,P<0.05)、血清肿瘤坏死因子α水平(2.11±0.26 ng/L比3.86±0.33 ng/L,P<0.05)以及脂肪组织肿瘤坏死因子αmRNA表达量(0.31±0.05比0.56±0.07,P<0.05)均显著降低。结论非诺贝特具有一定的抗动脉粥样硬化作用,其降低高胆固醇喂养兔血清肿瘤坏死因子α水平可能是其作用机制之一。 Aim To observe the anti-atheromatous effects of fenofibrate in cholesterol-fed rabbits male New Zeahed white rabbits were fed with high cholesterol diet for 8 weeks, and then were randomly divided into two groups: high cholesterol group maintained cholesterol diet for 4 weeks; fenofibrate treatment group maintained the same cholesterol diet hosides supplementing with fenofibrate [ 30 mg/( kg·d) ] for 4 weeks. And control group was fed with normal diet for 12 weeks. Before and after feeding, serum tumor necrosis factor-α (TNF-α ) levels of all rabbits were measured. After feeding, the aortas were harvested for observing the formation of atherosclerotic plaques. TNF-α mRNA expression in adipose tissue was evaluated by reverse transefiption-polymerase chain reaction (RT-PCR). Results High cholesterol group and fenofibrate treatment group showed higher serum levels of total cholesterol and low density lipoprotein cholesterol than those of control group (P〈0.001 ), but there were no difference between the two groups(P〉0.05). As compared with the high cholesterol group, aorlic atherosclerotic area (52.8%±6.9% vs 76.3%±8.6%, P〈0.01),intimal thickness of the aorta (28.45±5.68μm vs 76.18± 11.25μm, P〈0.05), serum TNF-α levels (2.11±0.26 ng/L vs 3.86±0.33 ng/L, P〈0.05) and TNF-α mRNA expression in adipose tissue (0.31±0.05 vs 0.56 vs 0.07, P〈0.05 ) were significantly decreased in fenofibrate treatment group. The study indicates that fenofibrate manifests an anti-atheromatous effect independent of the hypolipidemie effect in cholesterol-fed rabbits and decreasing serum TNF-α level may be one of its possible mechanisms.
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第4期313-316,共4页 Chinese Journal of Arteriosclerosis
关键词 内科学 非诺贝特具有抗动脉粥样硬化作用 半定量逆转录聚合酶链反应 非诺贝特 肿瘤坏死因子Α 斑块面积 动脉粥样硬化 Fenofibrate Atherosclerotic Plaque Area Tumor Necrosis Factor-α Atherosclerosis Intimal thickness Cholesterol-Fed Rabbits
  • 相关文献

参考文献16

  • 1Ross R. Atherosclerosis: an inflammatory disease[J]. N Engl J Med, 1999,340 (2) : 115-26
  • 2Garwal BB. Human Cytokines[M]. Edited by Aggarwal BB. Gutterman JU.Boston: Blackwell Scientific Publications,1992:270
  • 3Madej A, Okopien B, Kowalski J, Zielinski M, Wysocki J, Szygula B, et al.Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia Ⅱ b[J]. Int J Clin Pharmacol Ther, 1998, 36(6) : 345-349
  • 4Sacks FM. The relative role d LDL-cholestrol and HDL-cholesterol in coronary artery disease: evidence from large-scale statin fibrate trials[J].Am J Cardiol,2001, 88 (Suppl): 14N-8N
  • 5Pineda Torra I, Gervois P, Staels B. Peroxisome proliferator-activated receptor alpha in metabolic disease, inflammation, atherosclerosis and aging[J]. Curr Opin Lipidol, 1999, 10 (2): 151-159
  • 6徐也鲁.动脉粥样硬化——一种慢性炎症过程[J].中国动脉硬化杂志,2001,9(2):93-95. 被引量:187
  • 7范乐明.动脉粥样硬化炎症机制的再认识[J].中国动脉硬化杂志,2005,13(3):249-253. 被引量:75
  • 8Lei X, Buja LM. Detection and localization of tumor necrosis factor-α in WHHL rabbit arteries[J]. Atheroslerosis, 1996, 125(1):81-89
  • 9Wertheimer SJ, Myers CL, Wallace RW, Parks TP. Intercellular adhesion molecule-1 gene expression in human endothelial cells: differential regulation by TNF-alpha and phorbol myristate acetate[J]. J Biol Chem, 1992, 267(17):12030-035
  • 10Jovinge S, Hultgardh-Nilsson A, Regnstrom J, Nilsson J. Tumor necrosis factor-α activates smooth muscle cell migration in culture and is expressed in the ballcon-injured rat aorta[J]. Arterioncler Thromb Vasc Biol, 1997, 17(3):490-497

二级参考文献62

  • 1Yu H,Biochemistry,2000年,33卷,8期,601页
  • 2Roes R. Atherosclemsis - an inflammatory disease. N Engl J Med, 1999,340:115-126.
  • 3Cathcart MK. Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages contributions to atherosclerosis.Arterioscler Thromb Vasc Biol, 2004, 24(1): 23-28.
  • 4Rama Natarajan, Nadler JL.Lipid Inflammatory Mediators in Diabetic Vascular Disease.Arterioscler Thromb Vasc Biol,2004,24:1542-548.
  • 5Hosono M, de Boer OJ, van der Wal AC, van der Loos CM, Teeling P, Piek JJ,et al.Increased expression of T cell activation markers (CD25,CD26,CD40Land CD69)in atherectomy specimens of patients with unstable angina and acute myocardial infarction.Atherosclerosis,2003,168:73-80.
  • 6Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, Maseri A. Widespread coronary inflammation in unstable angina. N Engl J Med, 2002, 347(1): 5-12.
  • 7Libby P. Inflammation in atherosclemsis. Nature,2002,420:868-874.
  • 8Miller YI,Chang MK, Binder CJ, Shaw PX, Witztum JL. Oxidized low density lipoprotein and innate immune receptors. Curr Opin Lipidol, 2003, 14: 437-445.
  • 9Maggi E, Perani G, Falaschi F, Frattoni A, Martignoni A, Finardi G, et al.Autoantibodies against oxidized low density lipoproteins in patients with coronary disease. Presse Med, 1994, 23: 1158-162.
  • 10Mehta JL, Saldeen TG, Rand K. Interactive role of infection, inflammation and traditional risk factors in atherosclerosos and coronary artery disease. J Am Coll Cardiol, 1998, 31:1217-225.

共引文献255

同被引文献59

  • 1李世煌,张慧,段才闻,文小铃,严鹏科.氧化型低密度脂蛋白对血管平滑肌细胞小凹蛋白1表达的抑制作用及其与信号调节激酶的关系[J].中国动脉硬化杂志,2007,15(3):178-180. 被引量:4
  • 2李洁琪,赵水平,吴洁.非诺贝特抑制脂肪细胞组织因子表达[J].中国动脉硬化杂志,2004,12(5):565-567. 被引量:5
  • 3李俊明,马业新,黄俊.大鼠缺血再灌注心肌过氧化物酶体增殖物激活受体α的表达及血清游离脂肪酸含量的变化[J].中国病理生理杂志,2006,22(1):195-196. 被引量:3
  • 4Hartford M, Wiklund O, Mattsson Hulten L, et al. CRP, interleukin - 6, secretory phos- pholipase A2 group IIA, and intercellular ad- hesion molecule -1 during the early phase of acute coronary syndromes and long -term follow - up [ J]. Int J Cardiol, 2006,108 ( 1 ) : 55.
  • 5Bocher V, Chinetti G, Fruchart JC, et al. Role of the peroxisome proliferator - activated receptors (PPARS) in the regulation of lipids and inflammation control[ J ]. J Soc Biol, 2002,196( 1 ) :47 -52.
  • 6Li C, Browder W , Kao R. Early activation of transcription factor NF - kB during lschemia in perfused rat heart [ J ]. Am J Physical, 1999,276 : H543.
  • 7Baumann, Gauldie J. The acute phaseresponse [J]. I mmunol Today,1994,5:74 -80.
  • 8Yue TL, Bao W, Jucker BM, et al. Activa- tion of peroxisome proliferator - activated receptor - alpha protects the heart from ischemia/reperfusion injury [ J ]. Circulation, 2003, 108 (19) :2393 - 2399.
  • 9Brehm BR, Wolf SC, Bertsch D, et al. Effects of nebivolol on proliferation and apoptoeis of human coronary artery smooth muscle and endothelial cells [ J ]. Cardiovasc Res, 2001,49 (2) : 430-439.
  • 10Sakakibara K, Kubota K, Worku B, et al. PDGF-BB regulates p27 expression through ERK-clependent BNA turn-over in vascular smooth muscle cells [J]. J Biol Chem, 2005,280 (27) : 25 470-477.

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部